Education
About Us
Working with TipRanks
Follow Us
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -192.38K | $ -238.87K | $ -227.64K | $ -207.93K |
| Operating Income | $ -51.78M | $ -38.96M | $ -28.81M | $ -24.13M | $ -15.29M |
| EBITDA | $ -51.78M | $ -38.77M | $ -28.67M | $ -23.98M | $ -15.15M |
| Net Income | $ -44.58M | $ -37.98M | $ -28.60M | $ -23.97M | $ -14.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 23.29M | $ 9.56M | $ 19.87M | $ 35.70M | $ 57.17M |
| Total Assets | $ 25.47M | $ 12.08M | $ 21.59M | $ 37.20M | $ 58.66M |
| Total Debt | $ 494.00K | $ 552.98K | $ 603.83K | $ 301.74K | $ 421.64K |
| Net Debt | $ -22.79M | $ -9.01M | $ -19.26M | $ -35.40M | $ -56.74M |
| Total Liabilities | $ 11.18M | $ 25.85M | $ 6.08M | $ 4.16M | $ 3.86M |
| Stockholders' Equity | $ 14.29M | $ -15.16M | $ 15.51M | $ 33.05M | $ 54.79M |
| Cash Flow | |||||
| Free Cash Flow | $ -47.69M | $ -33.24M | $ -25.45M | $ -22.71M | $ -14.00M |
| Operating Cash Flow | $ -47.58M | $ -32.38M | $ -25.22M | $ -22.57M | $ -13.93M |
| Investing Cash Flow | $ -104.19K | $ -864.04K | $ -225.97K | $ -141.36K | $ -62.35K |
| Financing Cash Flow | $ 61.41M | $ 22.94M | $ 9.61M | $ 1.25M | $ 60.55M |